Pharmacokinetics of Ginsenoside Rb1, Rg3, Rk1, Rg5, F2, and Compound K from Red Ginseng Extract in Healthy Korean Volunteers.

Kim, Hyung Joong; Oh, Tae Kyu; Kim, Yoon Hee; Lee, Jaesun; Moon, Joo Myung; Park, Yong Sun; Sung, Chang Min

Kim, Hyung Joong; Oh, Tae Kyu; Kim, Yoon Hee; Lee, Jaesun; Moon, Joo Myung; Park, Yong Sun; Sung, Chang Min.

Affiliation

Kim HJ; R&D Center, BTC Corporation, No. 703, Technology Development Centre, Gyeonggi Technopark, 705 Haean-Ro, Sangnok-Gu, Ansan-Si, Gyeonggi-Do 15588, Republic of Korea.
Oh TK; R&D Center, BTC Corporation, No. 703, Technology Development Centre, Gyeonggi Technopark, 705 Haean-Ro, Sangnok-Gu, Ansan-Si, Gyeonggi-Do 15588, Republic of Korea.
Kim YH; R&D Center, BTC Corporation, No. 703, Technology Development Centre, Gyeonggi Technopark, 705 Haean-Ro, Sangnok-Gu, Ansan-Si, Gyeonggi-Do 15588, Republic of Korea.
Lee J; R&D Center, BTC Corporation, No. 703, Technology Development Centre, Gyeonggi Technopark, 705 Haean-Ro, Sangnok-Gu, Ansan-Si, Gyeonggi-Do 15588, Republic of Korea.
Moon JM; R&D Center, BTC Corporation, No. 703, Technology Development Centre, Gyeonggi Technopark, 705 Haean-Ro, Sangnok-Gu, Ansan-Si, Gyeonggi-Do 15588, Republic of Korea.
Park YS; R&D Center, Bio-Medieng Co., Ltd, No. 805, 137 Sagimakgol-Ro, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do, Republic of Korea.
Sung CM; Bestian Clinical Trial Center, 191 Osongsaengmyeong 1-Ro, Osong-Eup, Heungdeok-Gu, Cheongju-Si, Chungcheongbuk-Do 361-951 28161, Republic of Korea.

Evid Based Complement Alternat Med ; 2022: 8427519, 2022.

Article in En | MEDLINE | ID: mdl-35111231

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Evid Based Complement Alternat Med Year: 2022 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google